TACSTD2: Potential Drug Target and Biomarker for Various Diseases

Target Name: TACSTD2

NCBI ID: G4070

TACSTD2

TACSTD2: Potential Drug Target and Biomarker for Various Diseases

TACSTD2 (Epithelial Glycoprotein-1) is a protein that is expressed in the epithelial tissue of the body, including the skin, gut, and respiratory tract. It is a glycoprotein which means it consists of a protein and a carbohydrate. TACSTD2 is a member of the glycoprotein family 1 (GP1) and its protein sequence is similar to that of other glycoproteins of the same family.

TACSTD2 is a potential drug target and has been identified as a biomarker for various diseases, including cancer, diabetes, and cardiovascular disease. Its role in these diseases is not well understood, but it is known to play a role in the regulation of various cellular processes that are important for maintaining tissue health and function.

One of the main functions of TACSTD2 is its role in cell-cell adhesion. It is a member of the cadherin subfamily, which is a family of transmembrane proteins that play a central role in cell-cell adhesion. TACSTD2 is known to be involved in the regulation of cadherin interactions, which are important for the maintenance of tissue structure and the development of various diseases, including cancer.

In addition to its role in cell-cell adhesion, TACSTD2 is also involved in the regulation of cell growth and the maintenance of stem cell properties. It is known to play a role in the Wnt signaling pathway, a pathway that is important for the regulation of cell growth and the development of various tissues in the body.

TACSTD2 is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. It is known to play a role in the production of extracellular matrix (ECM) components, which are important for the formation of new blood vessels. This role in angiogenesis is important for the development and maintenance of various tissues in the body, including blood vessels, lungs, and the gut.

In addition to its role in cell-cell adhesion, TACSTD2 is also involved in the regulation of inflammation. It is known to play a role in the production of pro-inflammatory cytokines, which are important for the regulation of immune responses and the development of inflammatory diseases.

TACSTD2 is also involved in the regulation of pain perception. It is known to play a role in the production of nociceptins, which are important for the sensation of pain. This role in pain perception is important for the regulation of pain tolerance and the development of chronic pain.

In conclusion, TACSTD2 is a protein that is involved in a variety of cellular processes that are important for the maintenance of tissue health and function. Its role in cell-cell adhesion, cell growth, angiogenesis, inflammation, and pain perception makes it a potential drug target and a biomarker for various diseases. Further research is needed to fully understand the role of TACSTD2 in these processes and its potential as a drug.

Protein Name: Tumor Associated Calcium Signal Transducer 2

Functions: May function as a growth factor receptor

The "TACSTD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TACSTD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets